corporate presentation - alpek · this presentation contains, or may be deemed to contain,...

57
Corporate Presentation 3Q17

Upload: others

Post on 01-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Corporate Presentation

3Q17

Page 2: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

This presentation contains, or may be deemed to contain, “forward-

looking statements”. By their nature, forward looking statements involve

risks and uncertainties because they relate to events and depend on

circumstances that may or may not occur in the future. The future results

of Alpek, S.A.B. de C.V. And its subsidiaries may differ from the results

expressed in, or implied by the forward-looking statements set out

herein, possibly to a material degree.

20.5

Page 3: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Index

• Business Overview

• Consolidated Financials

• Appendix

Page 4: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Index

• Business Overview

• Consolidated Financials

• Appendix

Page 5: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Investment Highlights

5

Market-leading position in the Americas1

High-return integration and cost-saving projects3

Attractive consumer-oriented product portfolio2

4 Low cost producer with leading technology

5 Experienced management team

6 Strong free cash flow and financial performance

Page 6: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek is a leading petrochemical company focused

on Polyester chain products, mainly PTA and PET

Source: Alpek estimates

(1) September 2017 LTM

(2) 6.65% of the subsidiaries Akra Polyester, S.A. de C.V. and 8.55% Tereftalatos Mexicanos, S.A. de C.V., are owned by BP Amoco Chemical Co.

(3) 49% is owned by Lyondell Basell Industries Holdings B.V.

(4) 50% minus one share is owned by BASF de Mexico S.A. de C.V.6

Alpek Polyester2

PTA / PET Polyester Fibers

Polyester (72% of sales) Plastics & Chemicals (28% of Sales)

PolypropyleneExpandable

Polystyrene

Caprolactam

& FertilizersOthers

Indelpro3 Styropek Unimor Polioles4

Revenues1: US$ 5.1 Billion

EBITDA1: US$ 376 Million (US$ 489 Million ex-A/R impairment)

Page 7: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Source: Alpek

Polyester Chain

Gasoline

Reformer Paraxylene

Crude Oil

Fibers

PET

PTA

MEGEthyleneCrackerEthane

Naphtha Ethylene Oxide

Polyester

7

Page 8: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek´s products are widely used for food

packaging and consumer end-markets

Source: Alpek estimates

Kta: Thousand tons per year

Volume by Industry 2016(3,938 Kta)

Consumer

Goods

32%

Textiles

7%Construction

3%

Sales Geography 2016(4,838 Kta)

Europe

3%

Mexico

37%

USA

44%

Asia and Others

1%LatAm

14%

Food and

Beverages

58%

Canada

1%

8

Sample End Users by Industry

Beverage Food Personal care Textiles

Page 9: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek is the largest integrated polyester producer

in North America (PTA-PET)

Source: PCI adjusted with Alpek’s official capacities

2016 Capacities, 2016 M&As

PTA(5,550 kta)

Indorama

NanYa

M&G

42%

PET(4,391 kta)

North America

2016 Installed Capacity

9

BP

Indorama

Eastman

41%

29%

19%

10%

30%

25%

5%

Page 10: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek’s installed capacity amounts to 5.8 M tons;

23 production facilities and ~5,200 employees

Source: Alpek estimates

Kta: Thousand tons per year

(1) Includes industrial and specialty chemicals and recycled PET capacities

Location of Production Sites Installed Capacity Breakdown (Kta)

10

Site PTA PET rPET Fibers PP EPS CPL Other

Mexico

(2,950 Kta)

A Monterrey 160

B Altamira 1,000 640 165

C Salamanca 85

D Ocotlán 10

E Cosoleacaque 610 185

F Lerma 100

USA

(2,343 Kta)

G Cedar Creek 170 73

H Cooper River 170 150

I Columbia 640 725

J Pearl River 430

Canada K Selenis 144

Argentina

(225 kta)

L Zárate 190

M Pacheco 16

N General Lagos 19

Brazil O Guaratingueta 46

Chile

(27 Kta)

P Santiago 5

Q Puerto Montt 2

R Concon 20

Total Capacity1: 5,755 Kta 2,250 2,014 89 310 640 250 85 117

AB

CD EF

GIHJ

LMN

O

P

Q

R

K

Page 11: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek has developed a leading position in every

product of its portfolio

Source: PCI and Alpek estimates

(1) In North America

(2) In the Americas, including recent EPS acquisition

Alpek: Industry Position

Industry Position Comments

PTA #1 in North America • Attractive industry structure

• 41% est. installed capacity share1

PET#1 in North America

#2 Worldwide• 42% est. installed capacity share1

Fibers #2 in North America• Leading supplier of filament for car seatbelts

• 26% est. installed capacity share1

PP Only producer in Mexico • Attractive growth potential

EPS #1 in the Americas• Largest plant in the Americas

• 40% est. installed capacity share2

CPL Only producer in Mexico • Among top 5 lowest cost producers worldwide

Po

lye

ste

rP

las

tic

s &

Ch

em

ica

ls

11

Page 12: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek is investing in attractive organic projects to

boost profitability

Strategic Guidelines

Source: Alpek estimates

Project OverviewEstimated figures and dates

● Capture natural gas, ethane and propane

advantage in North America

● Maximize operating efficiency

● Selective capacity expansion

● Lever IntegRex® technology

12

ProjectCapex (US$M)

EBITDA (US$M)

Start-up

1. Cosoleacaque Cogeneration 140 30 4Q14

2. MEG Tolling Agreement 65 20 2Q16

3. Propylene Spheres (2) 23 10 2Q17

4. EPS Expansion Altamira 30 10 3Q17

5. Altamira Cogeneration 350 90 2018

6. PTA/PET Site (Corpus Christi) 435 100 TBD

Total ~ $1 B ~$260

US $965 M invested up to Sep-17

Page 13: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek also holds a successful M&A track record

and is constantly evaluating potential targets

Attractive Market Potential

Existing/Related Business

Cost Competitiveness

M&A Deals (2011-2016)M&A Guidelines

Product Capacity Year Country Investment

1. EastmanPTA /

PET1.3 Mtons 2011 USA US $622 M

2. Wellman PET 430 ktons 2011 USA US $123 M

3. Cabelma rPET 16 ktons 2014 Argentina Undisclosed

4. BASF EPS EPS 230 ktons 2015 The Americas Undisclosed

5. BASF (Concon) EPS 20 Ktons 2016 Chile Undisclosed

6. Selenis PET 144 ktons 2016 Canada Undisclosed

Alpek

M&A

7. Petroquimica

Suape (1)

PTA 700 ktons

2018

est.Brazil US $385 MPET 450 Ktons

Fibers 90 ktons

(1) Subject to corporate and governmental approvals after suspension imposed on the assets’ sale is resolved by Petrobras 13

Page 14: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

YTD Volume, Revenues and Capex in line with

guidance; EBITDA affected by M&G provision

3,0793,036

4,1063,9383,9373,931

20162015 2017G YTD17G2014 YTD17

-1%

Sales Volume Revenues

EBITDA CAPEX

Source: Alpek estimates

373

243

502

669630

434

2014

-35%

YTD17GYTD172017G20162015

200206238

345317320

+3%

2014 2017G YTD17GYTD1720162015

(Kto

ns

)

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

3,8553,910

5,0694,8385,284

6,471

+1%

YTD172014 YTD17G2017G20162015

% Sales 6.7% 9.9%11.9% 13.8%

14

6.2% 9.7%

Page 15: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

EBITDA vs. Guidance (YTD17)

US$M YTD17 YTD17G

Polyester 180 225

Plastics & Chemicals 170 149

Comparable 351 373

Inventory gain 6 -

M&G A/R Provision (113) -

Reported 243 373

Alpek EBITDA vs Guidance

2436212

12260

373

113

Secondary

feedstocks

(IPA)

Polyester

Outages

2Q17

YTD17

Ex-M&GYTD

17G

M&G A/R

Provision

Other YTD17Inventory

gain

-6%

15

Page 16: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Lower 2017 EBITDA guidance mainly due to

normalization of PP margins after 1Q16 peak

16

2723

8924

502

637669

EBITDA

2017G

Others

4

PolyesterComparable

EBITDA

2016

8

EPS

Margin

PP

Margin

Non

operating

items

EBITDA

2016

Inventory

gain

17

26

18

111111

2012 2013 2014 20162015 2017

Average Margin:

Polypropylene to Propylene (PGP)(c/lb)

181818

23

2830

26

20

15

11

20

2Q173Q173Q162Q16 1Q174Q162Q153Q15 1Q164Q151Q15

Alpek: EBITDA(M dls)

Page 17: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Relevant events – forward looking

● M&G’s financial distress

▪ Support M&G Altamira PET plant restart

▪ Focus on restructuring processes for M&G Mexico and Corpus Christi)

● Sale of Cosoleacaque and Altamira power cogeneration plants

▪ Exclusivity with ContourGlobal

● CADE approval process - PQS acquisition (Brazil)

● PET antidumping cases in U.S.A. and Canada

▪ USA: DOC and ITC investigations initiated 4Q17

▪ Canada: preliminary duties imposed in 4Q17 (22% - 77%)

17

Page 18: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Index

• Business Overview

• Consolidated Financials

• Appendix

Page 19: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Sales Volume and Revenues

+2%

77%78%

4,006

20162015

23%

3,937

23%

LTM 17

3,9383,931

24%22%

77%

2014

76%

Sales Volume Revenues

+4%

4,838

28%

5,0365,284

71%

LTM 17

27%

2015

27%

2016

71%

29%

6,471

2014

73%

73%

(Kta

)

(US

$ M

illi

on

)

Polyester Plastics & Chemicals

Source: Alpek estimates 19

Page 20: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Income Statement Accounts

532481

286

LTM 1720162014 2015

Operating Income EBITDA

Financial Cost, Net (1) Majority Net Income

Source: Alpek estimates

(1) Financial Cost, Net = Net Financial Expenses + Fx Gains (Losses) + Interest Rate Swaps + Gas & Comm. Derivatives

133116111

60

95

155

2015 20162014 LTM 17

198175

65

2016 LTM 172014 2015

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

11.0%9.1%4.4%% Sales

% Sales

4.1%3.3% -5.1%1.0%% Sales

669630

434

LTM 172014 20162015

13.8%11.9%6.7%

20

-3.9%

7.4%

489

376

155

ex-M&G347ex-M&G

ex-M&G

ex-M&G

201

261

Page 21: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Balance Sheet Accounts

488

694632

685

201620152014 Sep 17

Net Working Capital(1) Property, Plant and Equipment

Net Debt(2) Stockholders’ Equity

Source: Alpek estimates

(1) Net Working Capital = Accounts receivable + Other accounts receivable + Inventories - Suppliers - Other accounts payable and accrued expenses

(2) Net Debt = Bank loans and notes payable + Current portion of long term debt + Long term debt – Cash

2,1171,955

1,8201,861

201620152014 Sep 17

1,192

1,042

722715

2015 20162014 Sep 17

1,628

2,0192,0052,028

201620152014 Sep 17

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

505347 45NWC Days

21

Page 22: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Financial Ratios and Other Indicators

Interest Coverage(1)Net Debt / EBITDA

CAPEX

Source: Alpek estimates

(1) Interest coverage= EBITDA / Net financial expenses

7.0

10.7

6.5

201620152014 LTM 17

1.6

1.1

1.6

2.4

2014 2015 LTM 172016

3.2

280

345317320

LTM 172014 2015 2016

(Tim

es

)

(Tim

es

)

(US

$ M

illio

n)

170160

110

LTM 1720162014 2015

EBITDA / Ton

(US

$ / T

on

)

22

ex-M&G5.4

7.0 ex-M&G

ex-M&G

94

122

Page 23: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek Consolidated Debt Profile

September 2017

● Gross Debt: U.S. $1,639 million

● Net Debt: U.S. $1,192 million

● Available Committed Credit Lines: U.S. $171 million (Total: U.S. $430 million)

● 99% of our debt is denominated in US dollars(1)

(1) A small portion of debt is denominated in ARS

300

650

50

221

27

154

224

447

20232021202020192018 20222017Cash

23

Page 24: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Dividends paid to shareholders

143

111

95

114

100

129

20162015 20172014(1)20132012

(1) Paid in December2013

(US

$ M

illio

n)

24

Page 25: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Index

• Business Overview

• Consolidated Financials

• Appendix

Page 26: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Operating & Financial Highlights (3Q17)

Alpek

• One-time charges associated to Mossi & Ghisolfi (M&G): U.S. -$113 million

A/R provision (EBITDA), U.S. -$435 million intangible asset impairment (Oper.

Income), U.S. -$95 million financial asset impairment (Financial Cost, Net) and

U.S. +$223 million deferred tax

• 3.2 times Net Debt/LTM EBITDA; 2.4 times excluding M&G A/R provision (U.S.

-$113 million)

• Offers for power cogeneration assets in final selection stage

Polyester

• 3Q17 Polyester EBITDA of U.S.$ -51 million, including the U.S. -$113 million

M&G A/R provision and a U.S. $9 million non-cash inventory gain

• PTA supply to M&G was suspended in Mexico (Sep) and Brazil (Aug) due to

missed payments

• Alpek engaging M&G and its key creditors to resume PTA supply

Plastics &

Chemicals

(P&C)

• 3Q17 P&C EBITDA of U.S. $54 million; null inventory loss/gain

• Volume impacted by temporary feedstock supply disruptions, mainly due to

Hurricane Harvey

• Resilient margins in polypropylene (PP), expandable polystyrene (EPS) and

caprolactam (CPL)

26

Page 27: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Latest Quarter Results

Source: Alpek

(1) Times: Last 12 months.

Alpek: Selected Financial Information

27

(%) 3Q17 vs.

3Q17 2Q17 3Q16 2Q17 3Q16 YTD17 YTD16 Ch.%

Total Volume (ktons) 1,012 1,038 998 (2) 1 3,036 2,967 2

Polyester 788 807 757 (2) 4 2,353 2,254 4

Plastics & Chemicals 225 231 241 (3) (7) 683 713 (4)

Consolidated Revenues 1,312 1,306 1,236 - 6 3,910 3,655 7

Polyester 945 930 885 2 7 2,791 2,593 8

Plastics & Chemicals 367 375 351 (2) 4 1,119 1,062 5

Consolidated EBITDA 3 82 157 (96) (98) 243 536 (55)

Polyester (51) 33 83 (254) (161) 70 267 (74)

Plastics & Chemicals 54 49 73 10 (26) 173 270 (36)

Profit Attributable to Controlling Interest (400) 25 50

(1,719

) (903) (289) 170 (270)

CAPEX and Acquisitions 64 65 128 (2) (50) 206 270 (24)

Net Debt 1,192 1,058 915 13 30

Net Debt/LTM EBITDA(1) 3.2 2.0 1.3

Interest Coverage(1) 5.4 8.0 10.8

Page 28: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Latest Quarter Results

Sales Volume Revenues

EBITDA Majority Net Income

Source: Alpek

(Kto

ns

)

(US

$ M

illio

n)

(US

$ M

illio

n)

(US

$ M

illio

n)

967998981988 9701,038986

4Q1Q 2Q 3Q

143157

208

171

133

3

82

158

1Q 2Q 3Q 4Q

1,2191,2361,2371,182 1,1831,3061,293

4Q2Q 3Q1Q

295048

7228

-400

25

87

2Q1Q 4Q3Q

1.4% 6.1%

-97.9% -902.8%

Ch.% Ch.%

Ch.% Ch.%

0.3% -2.9%

-6.8% -4.2%

-0.2% 9.4%

-7.9% 20.4%

(US

$ M

illio

n)

5.8% 5.5%

-60.5% -48.5%

282015 2016 2017

1,012

ex-M&G

1,312

3

Page 29: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Latest Quarter Results

Source: Alpek

Alpek: Net Income

Alpek: Cash Flow

29

(%) 3Q17 vs.

3Q17 2Q17 3Q16 2Q17 3Q16 YTD17 YTD16 Ch.%

EBITDA 3 82 157 (96) (98) 243 536 (55)

Net Working Capital & Others 29 156 37 (81) (21) 121 (100) 221

Capital Expenditures & Acq. (64) (65) (128) 2 50 (206) (270) 24

Financial Expenses (17) (17) (18) (5) 5 (50) (41) (21)

Income tax (19) (33) (23) 43 18 (78) (142) 45

Dividends (71) (9) - (712) (100) (168) (205) 18

Payment affiliated companies - 1 (4) (100) 100 1 60 (99)

Other Sources / Uses 5 3 (25) 76 119 (13) (32) 60

Decrease (Increase) in Net Debt (135) 118 (4) (214) (2,947) (151) (193) 22

(%)3Q17 vs.

3Q17 2Q17 3Q16 2Q17 3Q16 YTD17 YTD16 Ch.%

Consolidated Net Income (394) 38 65 (1,140) (709) (251) 240 (205)

Non-Controlling Interest 6 13 15 (53) (58) 38 70 (45)

Controlling Interest (400) 25 50 (1,719) (903) (289) 170 (270)

Earnings per Share (U.S. Dollars) (0.19) 0.01 0.02 (1,719) (903) (0.14) 0.08 (270)

Avg. Outstanding Shares (Millions)* 2,117 2,117 2,118 2,117 2,118

Page 30: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Comparable EBITDA and 2017 Guidance (ex-M&G)

30

Reported EBITDA 2014 2015 2016 2017G 3Q16 3Q17 2016 2017

Polyester 270 344 349 304 157 (51) 267 70

Plastics & Chemicals 159 284 322 198 83 54 270 173

TOTAL 434 630 669 502 73 3 536 243

Comparable EBITDA 2014 2015 2016 2017G 3Q16 3Q17 2016 2017

Polyester 341 378 331 304 85 54 265 168

Plastics & Chemicals 159 273 308 198 67 54 356 170

TOTAL 505 654 637 502 152 108 520 338

Adjustments* 2014 2015 2016 2017G 3Q16 3Q17 2016 2017

Polyester 71 35 (18) - 2 105 (2) 98

Plastics & Chemicals - (11) (14) - (6) - (14) (3)

TOTAL 71 24 (32) - (4) 105 (16) 95

*Adjustments: Inventory and non-operating, one-time (gains) losses

Page 31: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Polyester Chain

PTA, PET, and Polyester Fibers

Employees: 3,629

Products (Capacity):

• PTA (2,250 Kta)

• PET (2,014 Kta)

• rPET (89 Kta)

• PSF (150 Kta)

• Filament and polymer (160 Kta)

Raw Materials:

• Paraxylene (Px)

• Monoethyleneglycol (MEG)

• Acetic Acid

End Markets:

• Food and beverage

• Textile

• Consumer Goods

EBITDA LTM 17

US$ 3,103 Million

Revenues LTM 17

US$ 152 Million

General Information

Source: Alpek 31

Pearl River, MI

PET

Cedar Creek, NC

PET, R-PET

Columbia, SC

PTA & PET

Cooper River, SC

PET & PSF

Monterrey, N.L.

Headquarters

Polyester Filament

Cosoleacaque, Ver.

PTA & PET

Altamira, Tamps.

PTA

Selenis, Quebec.

PET

ARG

Zárate, Arg.

PET

Pacheco, Arg.

PET

Page 32: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Plastics & Chemicals

PP, EPS, CPL and Others

General Information

Employees: 1,527

Products (Capacity):

• Polypropylene - PP (640 Kta)

• Expandable Polystyrene - EPS (250 Kta)

• Caprolactam - CPL (85 Kta)

• Other (117 Kta)

Raw Materials:

• Propylene, Styrene, Cyclohexane,

Ammonia, Sulfur, Pentane, Ethylene

Oxide, Propylene Oxide and Others

End Markets:

• Consumer Goods

• Food and Beverage

• Construction

EBITDA LTM 17

US$ 1,425 Million

Revenues LTM 17

US$ 226 Million

Ocotlán, Jal.

Nylon 6

Monterrey, N.L.

Headquarters,

Lerma, Edo. De Mex.

Specialty Chemicals

Altamira, Tamps.

PP, EPS

Salamanca, Gto.

CPL and Fertilizers

Guaratingueta, Brazil

EPS

Santiago, Chile

Other

Puerto Montt, Chile

Other

General Lagos, Argentina

EPS

32

Concon, Chile

EPS

Source: Alpek

Page 33: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek is managed by an experienced team focused

on delivering value to shareholders

Source: Alpek

Po

lye

ste

rP

las

tic

s&

Ch

em

ica

ls

Name PositionYears with

Alpek / Alfa

José de Jesús Valdez Simancas CEO 40

Eduardo Escalante Castillo CFO 29

Felipe Garza Medina Co-President, Alpek Polyester 39

Jorge Young Cerecedo Co-President, Alpek Polyester 26

Jorge González Escobedo President, Polyester Filaments 42

Alejandro Llovera Zambrano President, Polypropylene 31

José Luis Zepeda Peña President, EPS and Chemicals 30

Gustavo Talancón Gómez President, CPL and Ammonium Sulfate 27

Po

lye

ste

rP

las

tic

s&

Ch

em

ica

ls

33

Page 34: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Plastics & Chemicals

Organization Chart

Source: Alpek

Polyester Chain

Felipe GarzaCo-President

Alpek Polyester

Jorge YoungCo-President

Alpek Polyester

Alejandro Llovera

President, Polypropylene

Jorge GonzálezPresident, Polyester Filaments

Eduardo Escalante

CFO

José de Jesús ValdezCEO

José Luis Zepeda

President, EPS and Chemicals

Gustavo Talancón

President, CPL and Ammonium

Sulfate

34

Page 35: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Polypropylene Chain

Source: Alpek

Propylene

Refinery

Cracker

Polypropylene

35

Page 36: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Gasoline

Reformer Benzene

Refinery

Crude Oil

EPS

EPS & CPL Chain

Source: Alpek

Ethylene

Styrene

Cyclohexane Caprolactam

(CPL)

Cracker

Ammonia

36

Page 37: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

+ +

World leader in PP production with sales

in more than 100 countries

Largest petrochemical company in the

world with more than 370 sites

Alpek has been a reliable partner to other global

industry leaders through successful joint ventures

51.0%50.0%

+ 1 Share

Source: Alpek

Alpek: Sample Joint Ventures

37

Page 38: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek has grown at a 8% annualized rate since

1986 through M&A, JVs and organic projects

1985 1988 1991 1994 1997 2000 2003 2006 2009 2012 2015

PTA/PET acquisitions

(USA)

CabelmaPET

Coso Cogen

Acquisition of

Univex

(Caprolactam)

Clear Path

Recycling

Cogeneration

project

Acquisition of PTA

plant

Polypropylene plant

start-up

Propylene

splitter

installation

Acquisition of

polyester business

(USA)

Acquisition of Argentina

and Mexico PET plants

EPS expansion in

Altamira

IPO (BMV)

DMT

Expansion EPS

Expansion

Polypropylene

expansion

EPS

acquisition

Source: Alpek

Sales Volume 1986-2016(Index: 1986=100)

38

Selenis/ Concon

Acquisition

Page 39: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Organic growth and acquisitions position Alpek as

a leading PTA and PET producer in North America

2004(5,500 Kta)

2016(5,550 Kta)

2004 (3,800 Kta)

2016(4,931 Kta)

PTA – Installed Capacity(1)

PET – Installed Capacity(1)

InvistaInterquisa

Eastman

BP

Others

M&G

Indorama

NanYa

Wellman

Invista

Eastman

NanYa

M&G

IndoramaSource: PCI

(1) In North America

29%

41%

8%

42%

39

BP

Eastman

Indorama

Page 40: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Proprietary Technologies

(I&D, acquisitions)

Third-Party

Technologies

Alpek operates a state-of-the-art portfolio of

proprietary and third-party technologies

PTA

• Integrex PTA

PET

• Integrex PET

• Melt – TekTM

Oilfield Chemicals

• In-house

technology

Polypropylene

• Spheripol (LB)

• Spherizone (LB)

EPS

• Single Step

(BASF)

Caprolactam

• HSO

Alpek: Proprietary and Third-Party Technologies

Source: Alpek

40

Page 41: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Oxidation

Post-Oxidation

Filtration and

Drying

CTA Storage

Filtration and

Drying

Feed prep

Hydrogenation

Crystallization Crystallization

PTA Storage

Polymerization

Precursor

Storage

Esterification

Pre-Poly

Annealing

Solid State

Polymerization

Crystallization

PET Resin

Pelletization

Precursor

Preheating

Steps eliminated

with IntegRexTM

technology

Alpek’s IntegRex® technology simplifies both PTA

and PET production processes

Benefits from IntegRexTM technology:

• ~20% reduction in conversion cost

• ~US$15 less per ton in capital cost

• 11 less steps for the production of PTA and PET

• Lower wastewater by-product and greenhouse gas emissionsSource: Alpek

PTA / PET: Process Diagram

41

Page 42: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Power cogeneration overview

Contract-based

power

customers

Ga

s

turb

ine

Heat Recovery

Cogeneration plant

Ste

am

turb

ineNatural Gas

Electricity

Steam

Steam

12

3

1. Gas turbine generates electricity

2. Combustion gases produce steam

3. Steam is used to generate additional electricity and for Alpek’s chemical reactions

Hot

gases

42

Page 43: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

M&G’s Corpus Christi site capacity breakdown

420 Ktons

PTA1.3 M tons

M&G850 Ktons

500 Ktons

M&G600 Ktons

Pearl River

PET1.1 M tons

350 Ktons PTA

Corpus Christi Site (CC)

Raw materials(e.g. Px, MEG, etc.)

Raw materials(e.g. Px, MEG, etc.)

43

Page 44: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek has effectively transformed its EPS business

The Americas’ installed EPS capacity 2017ETotal: 600 ktons

Flint Hills

Nexkemia42%

Others

8%

Nova18%

17%

15%

Alpek

(Styropek)

32575

23065

165

20

2018Altamira

Expansion

Concon

Plant

2015Acquisition2014

Kta

Alpek: EPS capacityExpandable Polystyrene (EPS)

44

Page 45: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek acquired a controlling interest in Selenis

Canada Inc.

45

• Capacity: 144 Ktons (PET)

• Location: Montreal, Canada

• Rationale: • Only PET plant in Canada• Alpek to capture PTA integration synergies• Complement product portfolio with

differentiated PET products

Montreal. Canada

Charleston. USAColumbia. USA

Bay St. Louis. USA

Monterrey. México

Fayetteville. USA

Altamira. México

Cosoleacaque. México

Zárate. Argentina

Pacheco. Argentina

Alpek: Polyester production facilities

Polyester Plants (4,519 Kta)

Selenis Plant (144 Kta)

Selenis Plant

Page 46: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

U.S.A. PET antidumping case (2016)

Case Calendar

• March´15: Department of Commerce (DOC) and

International Trade Commission (ITC) filing

• March´16: DOC issued affirmative FINAL Antidumping

Duty and Countervailing Duty determinations

• April´16: ITC issued affirmative FINAL determinations

Countervailing Antidumping

Canada N/A 14 %

China 7 – 126 % 105 – 126 %

India 0 – 1541 % 8 – 19 %

Oman 0 % 8 %

(1) 154% only for JBF Industries Limited

Final Rates

46

• Rates applicable for a minimum period of five years.

• Trade orders could be renewed in five-year increments

Page 47: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

U.S.A. and Canada PET antidumping case (2017)

U.S. A.

● Petitions filed in September

▪ Department of Commerce (“DOC”) – initiated investigation (4Q’17)

▪ International Trade Commission (“ITC”) – initiated investigation (4Q’17)

Canada

● Canada Border Services Agency (“CBSA) initiated investigation in Aug-17

● Preliminary duties imposed in 4Q’17 (22%-77%); final resolution expected in 1Q’18 (duration 5 years)

Countries under investigation

U.S.A. Canada

• Brazil

• Indonesia

• South Korea

• Pakistan

• Taiwan

• China

• India

• Oman

• Pakistan

47

Page 48: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

2017 average Brent price estimated at $55/bbl

Brent Crude Oil

48

40

100

60

20

80

120

Dls/Bbl

99 $/bbl

53 $/bbl

2014 2015 2016 2017

44 $/bbl

Guidance 2017

($55/bbl)

• Δ 1 US$ dollar / Bbl = ~ Δ 3 US$ Million EBITDA

Page 49: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

981898

995926

871920

838882

948

1,168

9701,014

1,543

1,6351,708

1,003

2Q’164Q’15 2Q’173Q’15 1Q’17 3Q’173Q’161Q’16 4Q’162012 2Q’151Q’1520142011 2013 4Q’17

Px USA Contract Price

(US

$ / To

n)

Paraxylene (Px) Price

49

Page 50: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Propylene and Styrene Prices

North America Propylene Contract Price North America Styrene Spot Price

50494847

40393939

46

52

48

42

3638

33313133

42

50

70717073

JM SJAE F O4Q M A1Q 2Q3Q2Q 4Q1Q 3Q4Q 3Q1Q2Q DN

2014 2015 2016 2017

57

5352

60

55

504846

50

63

74

59

49

4446

4239

48

59

44

59

7171

75

AF J OME4Q J SM A3Q4Q4Q 2Q1Q1Q 3Q2Q2Q 1Q3Q DN

2014 2015 2016 2017

(c / lb

)

(c / lb

)

50

Page 51: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Margin: Asia PET to Px/MEG

(US

$ / To

n)

PET Margin (Asia)

2016

51

2017

PTA

PET

201

74 71 69 63 59 71 64 63 60 72 80 81

232

237222

214200

1Q14

230

258

13

284

210

270

212

12 15

394

3Q

210

240

1Q

263

4Q

276

2Q 4Q2Q 3Q11

260

China

250

Page 52: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

933

819

1,192

781

637647584

641704

985986

797

1,013

1,181

2,108

1,108

3Q2013 2Q1Q2Q1Q 3Q4Q2014 4Q 1Q 4Q20122011 3Q2Q

Margin: CPL Spot to Contract Benzene

(US

$ / To

n)

Caprolactam Margin (US)

52

2015 2016 2017

Page 53: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek stock highlights (BMV: ALPEK)

Valuation 4Q14 4Q15 4Q16 3Q17 3Q17 Proforma

Market Cap. (U.S.$ B) 2,475 3,113 2,193 2,228 2,228

Net Debt (U.S.$ M) 715 722 1,042 1,192 1,192

EBITDA LTM (U.S.$ M) 434 630 669 376 489

Enterprise Value / EBITDA 8.0 6.5 5.2 9.7 7.5

Price / Earnings 23.8 13.3 8.0 N/A 11.0

Price per Share (MXN) 17.78 25.98 21.10 20.00 20.00

Exchange Rate (MXN/USD) 15.21 17.67 20.35 19.00 19.00

3

1

6

5

4

3

5

1

2

0 0

2

6

4

DNOJ S OA F AJ MDN J SM JA

Daily Average Traded Shares & Value

2016

Daily Stock Price

(Pe

so

s)

20

25

30

35

15

40

Jun Sep Dec Jun SepMar Dec

2016

Performance ALPEK IPC DJI

December 2017 0.2% 4.8% 1.8%

YTD (Dec-17) -5.3% 8.1% 25.1%

Shares

Value ($)

(M Shares) (U.S. $ M)

53

20172017

Page 54: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

M&G Chemicals Overview

● Founded 1953 in Toronta, Italy

● Private company; no public debt or equity

● 20-yr comercial relationship w/Alpek(11% of Alpek sales)

PTA PET

Apple Grove (USA) 270

Altamira (Mexico) 560

Suape (Brazil) 550

Corpus Christi1 (USA) 864 600

About M&G Plant locations

Installed Capacity

1) Under construction; net of Alpek’s capacity reservation

Source: PCI

Altamira

Suape

Apple Grove

Corpus Christi1

54

Page 55: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Alpek’s exposure to M&G

US$M Guarantee

Capacity Reservation Corpus Christi 435 Corpus Christi assets (2nd lien)

Accounts Receivable 113 Unsecured

M&G Mexico Loan (Acquired) 100 M&G Mexico PET plant in Altamira (1st lien)

$90 M Loan 90 Corporate guarantees

55

Page 56: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

Non-recurring charges associated to M&G

Income Statement Balance Sheet

US$MYTD17

(ex-M&G)

M&G

ChargeYTD17

Operating Income 250 (548) (298)

Intangible asset impairment (435)

A/R Provision (113)

EBITDA 356 (113) 243

A/R Provision (113)

Financial cost, net (26) (95) (121)

Taxes (55) 223 168

Net income (loss) 169 (420) (251)

Profit (loss)attributable to

controlling interest127 (416) (289)

Net Debt 1,192 1,192

Net Debt / EBITDA 2.4 3.2

US$MSep-17

(ex-M&G)

M&G

ChargeSep-17

Assets 5,044 (481) 4,563

Trade accounts receivable 620 (113) 507

Intangible Assets – Cap Res 571 (360) 211

Other Assets – Cap Res 76 (75) 1

Other Assets – Loan 102 (95) 7

Other Assets – Deferred tax 20 162 182

Other Assets 3,655 - 3,655

Liabilities 2,996 (61) 2,935

Other Liabilities – Deferred tax 373 (61) 312

Other Liabilities 2,622 - 2,622

Stockholders’ Equity 2,048 (420) 1,628

Earned surplus 978 (420) 558

Others 1,070 - 1,070

56

Page 57: Corporate Presentation - Alpek · This presentation contains, or may be deemed to contain, “forward-looking statements”. By their nature, forward looking statements involve

North America PTA / PET capacity breakdown

Ktons USA Mexico Canada Total

Alpek 640 1,610 - 2,250

Indorama 1,050 - 600 1,650

BP 1,400 - - 1,400

Eastman 250 - - 250

Total 3,340 1,610 600 5,550

Ktons USA Mexico Canada Total

Alpek 1,495 185 144 1,824

Indorama 812 480 - 1,292

M&G 270 560 - 830

Nan Ya 445 - - 445

Total 3,022 1,225 144 4,391

PTA PET

Source: PCI adjusted with Alpek’s official capacities

2016 Capacities, 2016 M&As

North America

2016 Installed Capacity

57